Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
361.6500 -0.55 (-0.15%)
NSE Nov 17, 2026 11:36 AM
Volume: 506.8K
 

logo
Biocon Ltd.
13 Jan 2025
361.65
-0.15%
Motilal Oswal
Biocon (BIOS) has received ‘Voluntary Action Indicated’ (VAI) status for its Malaysian site. With this, BIOS now has all critical sites for biosimilars under USFDA compliance, improving its business prospects in the US market.
Institutional Investors have increased holdings from 31.52% to 37.94% in Sep 2026 qtr.
More from Biocon Ltd.
Recommended